Abstract
The work emphasizes the need for additional research to create novel biomarkers based on the use of microRNAs as a less invasive and precise diagnostic technique for identifying diseases in newborns.
Author Contributions
Copyright© 2024
Isea Raul.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests The authors have declared that no competing interests exist.
Funding Interests:
Citation:
Introduction
Traditional indicators, such as a newborn's weight and height, are still utilized since they can approximate a child's future risk of getting any disease. However, the implications of these indicators on the child's future adult development remain uncertain; for example, infants who are overweight or short in stature may suffer insulin insufficiency at birth, increasing their chances of developing diabetes as adults In fact, a mother's nutritional and hormonal state during pregnancy (including the postpartum period) can affect various aspects of his or her child's adult life, including the development of metabolic diseases like obesity, high blood pressure, hypercholesterolemia, hyperlipidemia, and so on One method for diagnosing potential abnormalities in neonates is the detection of acidosis, which is a pH shift in the umbilical cord that suggests hypoxic stress in the developing baby The majority of the diagnostic procedures done on babies in the first few days after delivery are called neonatal screening (NS) On the other hand, despite improvements in neonatal care and scientific knowledge, neonates may also die from sepsis, suffer significant impairment, or undergo neurological deterioration a condition that affects 4 out of 10 newborns on average in affluent nations It's important to remember that neonatal sepsis, along with other clinical symptoms and hemodynamic alterations that raise newborn morbidity and mortality, is a systemic inflammation brought on by bacteria, viruses, or fungi On the other hand, neonates with neonatal pneumonia (NE) are among the most common causes of death in neonatal intensive care unit (NICU) because of the high chance that they will experience neurological difficulties and disabilities throughout their lifetimes In parallel, microRNA was discovered during research on the nematode There is a growing focus on the application of microRNA-based biomarkers for real-time therapeutic decision-making in the context of neonatal sepsis and other disorders affecting neonates For example, Dakroub et al. Another example of how microRNAs benefit newborns is the range of macronutrients available in breast milk, which includes lactose, oligosaccharides, lipids, proteins, and nonprotein nitrogen. Breast milk is one of the most microRNA-rich biological fluids, with over 1400 distinct microRNAs accounting for approximately 25% of the total nitrogen in milk Two more examples. Ibrahim et al.'s study MicroARN are short ARN molecules ranging in size from 18 to 22 nucleotides that bind to ARNm, resulting in translational and genetic suppression, and are found in all eukaryotic cells Rapid advances in sequencing techniques have improved the sensitivity of detection, resulting in the discovery of several microRNAs in serum and blood The microRNA nomenclature involves the suffix "mir" and a unique identification number. The identification numbers are assigned progressively, independent of the organism. Identical or comparable miRNA sequences within a species might be assigned the same number. For example, the transcripts of The biosynthesis of microRNA involves several phases, beginning in the nucleus and ending in the cytoplasm MicroRNAs are small non-coding RNAs that regulate gene expression by silencing messenger RNAs (mRNA) An example of the application of microRNA-based biomarkers in the diagnosis of diseases is, for example, neonatal hypoxic-ischemic encephalopathy (HIE) Neonatal hypoxic brain damage (HIBI) is characterized by rapid free radical generation and enhanced biomolecule oxidation, particularly during the secondary phase